Dr. Rob Schott Joins Nutcracker Therapeutics as Chief Medical Officer

EMERYVILLE, Calif.–(BUSINESS WIRE)–Dr. Schott will oversee the advancement of Nutcracker Therapeutics’ oncology pipeline, helping to expand the company’s RNA therapeutics platform